Percutaneous interventions in adults with congenital heart disease: Expanding indications and opportunities

Current Cardiology Reports

Volumn 11, Issue 4, 2009, Pages 306-313

  Noble, Stéphane ^a   Ibrahim, Réda ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA COARCTATION; AORTA VALVE STENOSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CORONARY ARTERY FISTULA; CORONARY STENT; DECOMPRESSION SICKNESS; HEART ATRIUM SEPTUM DEFECT; HEART VALVE REPLACEMENT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG TERM CARE; LUNG BLOOD FLOW; MORBIDITY; MORTALITY; PATENT DUCTUS ARTERIOSUS; PATENT FORAMEN OVALE; PERCUTANEOUS CORONARY INTERVENTION; PULMONARY VALVE STENOSIS; REVIEW; SURGICAL APPROACH; TRANSLUMINAL VALVULOPLASTY; TREATMENT INDICATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; STENTS;

EID: 67650296714     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-009-0044-6     Document Type: Review

References (44)

1. Hoffman JL: Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995, 16:103-113.
2. Warnes CT, Liberthson R, Danielson GK, et al.: Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001, 37:1170-1175.
3. Hoffman JI, Kaplan S, Liberthson RR: Prevalence of congenital heart disease. Am Heart J 2004, 147:425-439.
4. Garson A Jr, Allen HD, Gersony WM, et al.: The cost of congenital heart disease in children and adults: A model for multicenter assessment of price and practice variation. Arch Pediatr Adolesc Med 1994, 148:1039-1045.
5. Warnes CA, Williams RG, Bashore TM, et al.: ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52: E1-e121.
6. Sommer RJ, Hijazi ZM, Rhodes JF Jr: Pathophysiology of congenital heart diSease in the adult: Part I: shunt lesions. Circulation 2008, 117:1090-1099.
7. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984, 59:17-20.
8. Rosamond W, Flegal K, Furie K, et al.: Heart disease and stroke statistics - 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25-e146.
9. Landzberg MJ, Sloss LJ, Faherty CE, et al.: Orthodeoxia-platypnea due to intra-cardiac shunting: Relief with transcatheter double umbrella closure. Cathet Cardiovasc Diagn 1995, 36:247-250.
10. Germonpre P, Balestra C: Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J 2004, 25:2173-2174.
11. Allemann Y, Hutter D, Lipp E, et al.: Patent foramen ovale and high altitude pulmonary edema. JAMA 2006, 296:2954-2958.
12. Sommer RJ, Hijazi ZM, Rhodes JF: Pathophysiology of congenital heart diseCse in the adult: Part III: complex congenital heart disease. Circulation 2008, 117:1340-1350.
13. Messé S, Kasner S: Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: Not to close. Circulation 2008, 118:1999-2004.
14. WinIecker S, Meier B: Closure: is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: To close or not to clWse. Closure: what else! Circulation 2008, 118:1989-1997.
15. Inglessis I, Landzberg M: Interventional catheterization in adult congenital heart disease. Circulation 2007, 115:1622-1633.
16. Mullen MJ, Hildick-Smith D, De Giovanni JV, et al.: Bio-STAR Evaluation STudy (BEST): A prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 2006, 114:1962-1967.
17. Hara H, Jones T, Ladich E, et al.: Patent foramen ovale closure by radiofrequency thermal coaptation. First experience in the porcine model and healing mechanisms over time. Circulation 2007, 116:648-653.
18. Lindsey JB,AHillis LD: Clinical update: atrial septal defect in adults. Lancet 2007, 369:1244-1246.
19. Brickner ME, Hillis LD, Lange RA: Congenital heart disease in adults: first of two parts. N Engl J Med 2000, 342:256-263.
20. King TD, Mills NL: Nonoperative closure of atrial septal defects. Surgery 1974, 75:383-388.
21. Brochu MC, Baril JF, Dore A, et al.: Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation 2002, 106:1821-1826.
22. Fischer G, Stieh J, Uebing A, et al.: Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: A single centre study in 236 consecutive patients. Heart 2003, 89:199-204.
23. Du ZD, Hijazi ZM, Kleinman CS, et al.: Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: Results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002, 39:1836-1844.
24. Dhillon R, Thanopoulos B, Tsaousis G, et al.: Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart 1999, 82:559-562.
25. Du ZD, Koenig P, Cao QL, et al.: Comparison of transcatheter closure of secundum atrial septal defect using the Amplatzer septal occluder associated with deficient versus sufficient rims. Am J Cardiol 2002, 90:865-869.
26. Kort HW, Balzer DT, Johnson MC: Resolution of right heart enlargement after closure of secundum atrial septal defect with transcatheter technique. J Am Coll Cardiol 2001, 38:1528-1532.
27. Menon V, Webb JG, Hillis LD, et al.: Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: A report from the SHOCK trial registry. Should we emergently revascularize occluded coronaries in cardiogenic shock? J Am Coll Cardiol 2000, 36(3 Suppl A):1110-1116.
28. Noble S, Ibrahim R: Transcatheter membranous ventricular septal defect closure through a mechanical aortic prosthesis using the Amplatzer membranous ventricular septal defect occluder. Catheter Cardiovasc Interv 2009, 2:167-172.
29. Holzer R, Latson L, Hijazi Z: Device closure of iatrogenic membranous ventricular septal defects after prosthetic aortic valve replacement using the Amplatzer membranous ventricular septal defect occluder. Catheter Cardiovasc Interv 2004, 62:276-280.
30. Holzer R, de Giovanni J, Walsh KP, et al.: Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006, 68:620-628.
31. Bass JL, Kalra GS, Arora R, et al.: Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv 2003, 58:238-245.
32. Tucker EM, Pyles LA, Bass JL, Moller JH: Permanent pacemaker for atrioventricular conduction block after operative repair of perimembranous ventricular septal defect. J Am Coll Cardiol 2007, 50:1196-1200.
33. Butera G, Carminati M, Chessa M, et al.: Transcatheter closure of perimembranous ventricular septal defects: Early and long-term results. J Am Coll Cardiol 2007, 50:1189-1195.
34. Thanopoulos BV, Rigby ML, Karanasios E, et al.: Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder. Am J Cardiol 2007, 99:984-989.
35. Krasuski R, Bashore T: The emerging role of percutaneous intervention in adults with congenital heart disease. Rev Cardiovasc Med 2005, 6:11-22.
36. Porstmann W, Wierny L, Waarnke H: Closure of ductus arteriosus persistens without thoracotomy. Fortschr Geb Roengenstr Nuklearmed 1968, 109:133-148.
37. Armsby LR, Keane JF, Sherwood MC, et al.: Management of coronary artery fistulae. Patient selection and results of transcatheter closure. J Am Coll Cardiol 2002, 39:1026-1032.
38. Driscoll DJ, Michels VV, Gersony WM, et al.: Occurrence risk for congenital heart defects in relatives of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 1993, 87(Suppl I):I-114-I-120.
39. Hayes CJ, Gersony WM, Driscoll DJ, et al.: Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis. Circulation 1993, 87(2 Suppl):I28-I37.
40. Rhodes J, Hijazi Z, Sommer R, et al.: Pathophysiology of congenital heart disease in the adult, part II. Simple obstructive lesions. Circulation 2008, 117:1228-1237.
41. Lurz P, Coats L, Khambadkone S, et al.: Percutaneous pulmonary valve implantation of evolving technology and learning curve on clinical outcome. Circulation 2008, 117:1964-1972.
42. Garay F, Webb J, Hijazi Z: Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: First report in a human patient. Catheter Cardiovasc Interv 2006, 67:659-662.
43. Singer MI, Rowen M, Dorsey TJ: Transluminal aortic balloon angioplasty for coarctation of the aorta in the newborn. Am Heart J 1982, 103:131-132.
44. Asgar A, Mirò J, Ibrahim R: Recanalization of systemic venous baffles by radiofrequency perforation and stent implantation. Catheter Cardiovasc Interv 2007, 70:591-594.